Compliance bei Arzneimitteln: ein unterschätztes Problem
- 7 Downloads
Compliance with medication: an underestimated problem
Non-Compliance with the prescribed medications has been a common concern in medical practice for a long time. Patients do not fully adhere to their prescriptions for medications or do not continue with their medications for as long as is recommended even when their conditions are potentially life threatening. As a consequence, this behavior may not only harm the individual patient by reducing the potential benefits of drug therapy, requiring additional treatment, but it does also lead to a wasting of resources. In this paper, we review studies that address the true dimensions of the problem, the factors involved, and the strategies used to improve compliance. Our findings document that in order to improve compliance, combined strategies such as a cooperative patient-doctor-relationship, promotion of patient self-management, or simplification of the drug regimen by combination therapy and therapy plans have the highest success rate. Further research on strategies to reduce non-compliance, the impact of non-compliance on health outcomes, and on health costs are needed.
Unable to display preview. Download preview PDF.
- 1.Nichols-English G, Poirier S. Optimizing adherence to pharmaceutical care plans. J Am Pharm Assoc (Wash) 2000 Jul–Aug; 40(4): 475–85Google Scholar
- 2.Royal Pharmaceutical Society of Great Britain. From Compliance to concordance: towards shared goals in medicine taking. London: RPS, 1997Google Scholar
- 6.Arnet I, Haefeli WE. Compliance: Fakten-Perspektiven. Managed Care 1998; 3: 27–30Google Scholar
- 9.DiMatteo MR, DiNicola DD. Achieving patient compliance. New York: Pergamon, 1982.Google Scholar
- 13.Meredith PA, Elliott HL: Therapeutic coverage: reducing the risks of partial compliance. Br J Clin Pract 1994 May; Suppl 73: 13–7Google Scholar
- 15.Cramer JA, Mattson RH. Monitoring compliance with antiepileptic drug therapy. In: Cramer JA, Spilker B, eds. Patient compliance in medical practice and clinical trials. New York: Raven Press, 1991: 123–37Google Scholar
- 20.Volmer T, Kielhorn A. Compliance und Gesundheits-ökonomie. In: Compliance und Selbstmanagement, Petermann, F (Hrsg.), Göttingen: Hogrefe 1998: 45–72Google Scholar
- 24.Sung JCY, Nichol MB, Venturini F, et al: Factors affecting patient compliance with antihyperlipidemic medications in an HMO population. Am J Managed Care 1998 Oct; 4(10): 1421–30Google Scholar
- 30.Haynes RB: A critical review of the determinants of patient compliance with therapeutic regimens. Compliance in health care. In: Haynes RB, Taylor DW, Sackett DL. London: The Johns Hopkins University Press Baltimore, 1979Google Scholar
- 33.Gottlieb H. Medication nonadherence: finding solutions to a costly medical problem. Drug Benefit Trends 2000; 12: 57–62Google Scholar